Smitvi Smitvi
Resultados de pesquisa
Veja todos os resultados
  • Acessar
    Entrar
    Cadastrar
    Pesquisar

Pesquisar

Conheça novas pessoas, crie conexões e faça novos amigos

  • Feed de notícias
  • Competitions
    • All Competitions
    • My Competitions
    • • Ativo
    • • Past
    • • Won
  • EXPLORAR
  • Grupos
  • Blogs
  • Jobs
  • Courses
  • Publicações
  • Blogs
  • Usuários
  • Grupos
  • Subodh Adke adicionou um novo artigo Outro
    2026-05-05 11:48:33 -
    (R)-N-Boc-3-(Aminomethyl)Pyrrolidine Market 2026–2034: Chiral Pharmaceutical Intermediates Driving CNS, Oncology, and Antiviral Drug Development
    (R)-N-Boc-3-(Aminomethyl)Pyrrolidine market was valued at USD 28.4 million in 2025 and is projected to reach USD 58.2 million by 2034, exhibiting a remarkable CAGR of 7.4% during the forecast period.  (R)-N-Boc-3-(Aminomethyl)Pyrrolidine is a specialized chiral pyrrolidine derivative featuring a tert-butoxycarbonyl (Boc) protecting group and an aminomethyl substituent at the 3-position....
    0 Comentários 0 Compartilhamentos 79 Visualizações 0 Anterior
    Faça o login para curtir, compartilhar e comentar!
  • Subhayan Mayra adicionou um novo artigo Outro
    2026-04-15 11:50:17 -
    Brigatinib API Market Growing at 8.1% CAGR Through 2034 Globally
    According to a new report from Intel Market Research, the global Brigatinib API market was valued at USD 42.5 million in 2025 and is projected to reach USD 89.7 million by 2034, growing at a robust CAGR of 8.1% during the forecast period (2026–2034). This growth is propelled by the increasing global incidence of non-small cell lung cancer, particularly ALK-positive cases among...
    0 Comentários 0 Compartilhamentos 440 Visualizações 0 Anterior
    Faça o login para curtir, compartilhar e comentar!
  • Subhayan Mayra adicionou um novo artigo Outro
    2026-04-20 11:24:45 -
    Global Multi-target MET TKIs Market Growing at 7.6% CAGR Through 2034
    According to a new report from Intel Market Research, the global Multi-target MET TKIs market was valued at USD 1.52 billion in 2025 and is projected to reach USD 3.18 billion by 2034, growing at a CAGR of 7.6% during the forecast period (2026–2034). This growth is propelled by the rising global incidence of non-small cell lung cancer and medullary thyroid cancer, precision oncology...
    0 Comentários 0 Compartilhamentos 398 Visualizações 0 Anterior
    Faça o login para curtir, compartilhar e comentar!
© 2026 Smitvi Portuguese (Brazil)
English Arabic French Spanish Portuguese Deutsch Turkish Dutch Italiano Russian Romaian Portuguese (Brazil) Greek
Contact Disclaimer Sobre Terms & Conditions Privacidade Fale conosco Diretório